T1	Participants 91 133	patients with metastatic colorectal cancer
T2	Participants 136 242	One hundred twenty-two chemotherapy-naive patients with histologically confirmed colorectal adenocarcinoma
T3	Participants 1509 1552	patients with advanced colorectal carcinoma
T4	Participants 1624 1644	colorectal carcinoma
